国产成人高清精品免费软件,免费无码日产av,亚洲中文字幕无码中字狠狠,国产又黄又爽又刺激的免费网址,天堂网亚洲综合在线,激情综合激情,国产精品视频第一专区,国产日韩精品秘 入口
Language:
簡體
/
繁體
/
English
Luoxin Introduction
Luoxin Products
Sales Network
Contact Us
Home
About Luoxin
News
Products
Research Center
HR
Social Responsibilities
Company profile
Development History
Enterprise Culture
Cooperative Partners
Qualification & Honor
Contact Us
Luoxin Pharmaceutical,Source of Health
Company News
Upcoming Events
Luoxin Pharmaceutical,Source of Health
Products
Luoxin Pharmaceutical,Source of Health
R&D Platform
R&D Strategy
R&D Achievements
Luoxin Pharmaceutical,Source of Health
Talent Concept
Talents cultivation system
Luoxin Academy
Luoxin Pharmaceutical,Source of Health
Concept of Social Responsibility
Social Responsibilities programs
Footprints of Public Service
Luoxin Pharmaceutical,Source of Health
Company News
Luoxin Pharmaceutical signs licensing agreement with Austria-based Marinomed Biotech AG for Budesolv? Budesonide Nasal Spray
2021.10.29
SHANGHAI, China -- On October 19, 2021-- Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. (‘’Shandong Luoxin’’), a subsidiary of Luoxin Pharmaceutical Group Stock Co., Ltd. (“Luoxin Pharmaceutical” or “the company”) , signed a licensing agreement with Austria-based Marinomed Biotech AG (“Marinomed”), whereby Shandong Luoxin will gain the exclusive rights for the development, manufacture, and commercialization of Budesolv? (Budesonide Nasal spray) in China (including Chinese mainland, Hong Kong and Macao SAR, Taiwan region). The signing of the license agreement will further expand Luoxin Pharmaceutical’s product line and enhance Luoxin’s competitive edge in the area of respiratory diseases.
More
Luoxin Pharmaceutical Signed a Cooperation Agreement with HK inno.N Corporation
2021.07.07
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.(Shandong Luoxin), a subsidiary of Luoxin Pharmaceutical Group Stock Co., Ltd. (Luoxin Pharmaceutical) signed a cooperation agreement with South Korea-based HK inno.N Corporation (formerly CJ HealthCare Corporation) whereby Shandong Luoxin will gain the exclusive rights for the development, manufacture, and commercialization of Tegoprazan injections in China. At present, Tegoprazan injections are not yet available anywhere worldwide. The signing event took place online.
More
Luoxin Pharmaceutical announced the signing of the exclusive development agreement of the three-chamber total parenteral nutrition product with JW Holdings
2020.10.26
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. , subsidiary of Luoxin Pharmaceutical Group Stock Co., Ltd. (Stock Code: 002793, hereinafter referred to as "Luoxin Pharmaceutical"), signed an exclusive license and distribution agreement with JW Holdings through an online ceremony this morning. The agreement grants Luoxin Pharmaceutical the exclusive right to develop and commercialize Winuf? under JW Holdings in the Chinese mainland, Hong Kong and Macau. Winuf? is a three-chamber total parenteral nutrition (TPN) product and so far there are no commercialized TPN products containing refined fish oil on the Chinese market. Besides, JW Holdings is the first Asian TPN manufacturer certified by European GMP.
More
Luoxin Pharmaceutical: Potassium-competitive Acid Blocker (P-CAB) LXI-15028 Phase III Trial Meets Primary Endpoint
2019.11.27
Shanghai, China, December 27, 2019- Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. (“Luoxin Pharmaceutical”) announced today, the innovative investigational product, potassium-competitive acid blocker (P-CAB), has met the primary endpoint in the multi-center, randomized, double-blind, parallel-group controlled phase III study to evaluate the efficacy and safety of LXI-15028 for the patients with erosive esophagitis during up to 8-week treatment, compared to Esomeprazole.
More
Luoxin Pharmaceutical announced the company has reached an agreement with Aurobindo Pharma to establish a joint venture company in China
2018.12.25
Shanghai, China - Dec, 23 2018 -- Shandong Luoxin Pharmaceutical Group (hereinafter referred to as "Luoxin Pharmaceutical") today announced the company has reached an agreement with Aurobindo Pharma Co., Ltd. (hereinafter referred to as "Aurobindo Pharma") to establish a joint venture company in China and invest in both R&D and manufacturing systems on respiratory products. Aurobindo Pharma will transfer respiratory products and technical know-hows with technologic barriers to China for local manufacturing; the joint venture company will possess numerous products approved by US FDA and EMA, and manufacture respiratory products to supply China, US and EU markets to provide more and better options for patients in those regions.
More
1
Company News
Upcoming Events
News
Charity Campaign
主站蜘蛛池模板:
国产精品极品美女自在线
|
久久综合激情网
|
黄色网站在线观看无码
|
无套av在线
|
香蕉视频国产精品人
|
亚洲一区二区三区香蕉
|
又黄又湿又爽的视频
|
国产新AV天堂
|
99久久精品久久久久久婷婷
|
欧亚日韩Av
|
台湾AV国片精品女同性
|
日韩AV手机在线观看蜜芽
|
亚洲精品无码不卡在线播放
|
亚洲欧美一区二区三区图片
|
日韩av资源在线
|
精品一區二區久久久久久久網站
|
日韩小视频在线播放
|
亚洲人成在线免费观看
|
国产成人免费视频精品一区二区
|
99国产在线视频
|
五月天丁香婷婷综合久久
|
精品三级在线
|
欧美劲爆第一页
|
成人a免费α片在线视频网站
|
国产丝袜第一页
|
www.精品视频
|
99久久精彩视频
|
中文字幕久久波多野结衣
|
亚洲六月丁香六月婷婷蜜芽
|
欧美成人二区
|
亚洲人成电影在线播放
|
国产成人综合日韩精品无码首页
|
国产成人亚洲综合a∨婷婷
|
一个色综合久久
|
免费看a级毛片
|
狠狠综合久久
|
国产本道久久一区二区三区
|
99久久国产综合精品2020
|
国产午夜人做人免费视频中文
|
国产迷奸在线看
|
欧美国产日韩在线观看
|
波多野结衣AV无码久久一区
|
国产精品自在在线午夜区app
|
中文字幕在线看视频一区二区三区
|
亚洲欧美激情小说另类
|
大学生久久香蕉国产线观看
|
片在线无码观看
|
91精品久久久久久无码人妻
|
国产小视频免费
|
精品久久综合1区2区3区激情
|
久久不卡国产精品无码
|
亚洲熟女偷拍
|
亚洲精品另类
|
久草国产在线观看
|
亚洲成A人V欧美综合天堂
|
91黄视频在线观看
|
91九色视频网
|
亚洲成人动漫在线
|
yjizz视频最新网站在线
|
亚洲综合激情另类专区
|
亚洲AV无码久久天堂
|
国产噜噜噜
|
国产福利一区二区在线观看
|
久久综合九色综合97婷婷
|
国产成人凹凸视频在线
|
欧美在线综合视频
|
精品亚洲麻豆1区2区3区
|
国产精品精品视频
|
成人午夜网址
|
国产黄色片在线看
|
国模极品一区二区三区
|
嫩草在线视频
|
国产国模一区二区三区四区
|
国产麻豆精品在线观看
|
日韩黄色在线
|
亚洲欧美综合在线观看
|
日韩毛片免费视频
|
无码网站免费观看
|
超级碰免费视频91
|
99这里只有精品免费视频
|
免费又黄又爽又猛大片午夜
|
国产精品嫩草影院视频
|